Acutus Medical (AFIB) Stock Price, News & Analysis

Company Overview

Acutus Medical, Inc. was a medical technology company focused on improving the diagnosis and treatment of cardiac arrhythmias, particularly atrial fibrillation. Headquartered in Carlsbad, California, the company developed technologies for cardiac electrophysiology procedures, which use catheters and imaging systems to identify and treat abnormal heart rhythms.

Its principal product was the AcQMap 3D Imaging and Mapping System, designed to create detailed, real-time maps of the heart’s electrical activity and anatomy. The system was intended to help physicians locate sources of arrhythmias and guide catheter ablation procedures. Acutus also developed related electrophysiology products, including mapping catheters, access sheaths and other procedural tools.

Founded in 2011, Acutus Medical served hospitals and electrophysiology specialists in the United States and select international markets. The company became publicly traded on the Nasdaq under the symbol AFIB in 2020. Its subsequent corporate operations and product ownership changed as the company pursued strategic alternatives, so historical descriptions of Acutus Medical primarily relate to its cardiac mapping and ablation technology business.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 7,037 shs
• Market Capitalization: $3 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 11/11/2021
• Today: 9/26/2026
• Next Earnings (Estimated): 11/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:AFIB
• CIK: 1522860
• Web: www.acutusmedical.com
• Phone: 442-232-6080
• Fax: 442-232-6081
• Employees: 85
• Year Founded: 2011

Profitability

• EPS (Trailing Twelve Months): ($0.11)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$81.66 million
• Net Margins: -272.74%
• Pretax Margin: -30.32%
• Return on Equity: -311.64%
• Return on Assets: -11.57%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.85
• Quick Ratio: 1.57

Sales & Book Value

• Annual Sales: $7.16 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.03) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 29,912,000
• Free Float: 28,228,000
• Market Cap: $3 thousand
• Optionable: No Data
• Beta: 5.73